Advances in Bioartificial Liver Assist Devices

Abstract: Rapid advances in development of bioartificial liver assist devices (BLADs) are exciting clinical interest in the application of BLAD technology for support of patients with acute liver failure. Four devices (Circe Biomedical HepatAssist®, Vitagen ELAD™, Gerlach BELS, and Excorp Medical BLSS) that rely on hepatocytes cultured in hollow‐fiber membrane technology are currently in various stages of clinical evaluation. Several alternative approaches for culture and perfusion of hepatocytes have been evaluated in preclinical, large animal models of liver failure, or at a laboratory scale. Engineering design issues with respect to xenotransplantation, BLAD perfusion, hepatocyte functionality and culture maintenance, and ultimate distribution of a BLAD to a clinical site are delineated.

[1]  N. Marceau,et al.  Spheroidal aggregate culture of rat liver cells: histotypic reorganization, biomatrix deposition, and maintenance of functional activities , 1985, The Journal of cell biology.

[2]  T. Tsuji,et al.  Glycosaminoglycans partially substitute for proteoglycans in spheroid formation of adult rat hepatocytes in primary culture. , 1988, Cell structure and function.

[3]  T. Chang,et al.  A novel two step procedure for immobilizing living cells in microcapsules for improving xenograft survival. , 1991, Biomaterials, artificial cells, and immobilization biotechnology : official journal of the International Society for Artificial Cells and Immobilization Biotechnology.

[4]  C. Cooney,et al.  Model of oxygen transport limitations in hollow fiber bioreactors , 1991, Biotechnology and bioengineering.

[5]  T. Chang.  Hybrid artificial cells: microencapsulation of living cells. , 1992, ASAIO journal.

[6]  T. Chang.  Artificial liver support based on artificial cells with emphasis on encapsulated hepatocytes. , 2008, Artificial organs.

[7]  V. Dixit.  Development of a bioartificial liver using isolated hepatocytes. , 1994, Artificial organs.

[8]  F W Schildberg,et al.  Collagen Gel Immobilisation Provides a Suitable Cell Matrix for Long Term Human Hepatocyte Cultures in Hybrid Reactors , 1994, The International journal of artificial organs.

[9]  D. Cassio,et al.  Application of spheroid culture to human hepatocytes and maintenance of their differentiation , 1994, Biology of the cell.

[10]  R. Hughes,et al.  Evaluation of the BioLogic-DT sorbent-suspension dialyser in patients with fulminant hepatic failure , 1994, The International journal of artificial organs.

[11]  N. Sussman,et al.  Extracorporeal liver support. Application to fulminant hepatic failure. , 1994, Journal of clinical gastroenterology.

[12]  F. Cerra,et al.  Gel-entrapment bioartificial liver therapy in galactosamine hepatitis. , 1995, The Journal of surgical research.

[13]  F. Cerra,et al.  An anesthetized model of lethal canine galactosamine fulminant hepatic failure , 1995, Hepatology.

[14]  J. Gaylor,et al.  Techniques for Measurement of Oxygen Consumption Rates of Hepatocytes during Attachment and Post-Attachment , 1996, The International journal of artificial organs.

[15]  G Catapano,et al.  Mass Transfer Limitations to the Performance of Membrane Bioartificial Liver Support Devices , 1996, The International journal of artificial organs.

[16]  J. C. Gerlach,et al.  Consideration of Potential Immunological Problems in the Application of Xenogenic Hybrid Liver Support , 1996, The International journal of artificial organs.

[17]  A. Demetriou,et al.  Clinical Experience with a Porcine Hepatocyte-Based Liver Support System , 1996, The International journal of artificial organs.

[18]  J. Stange,et al.  Hepatocyte Encapsulation - Initial Intentions and New Aspects for Its Use in Bioartificial Liver Support , 1996, The International journal of artificial organs.

[19]  G. Michalopoulos,et al.  Population expansion, clonal growth, and specific differentiation patterns in primary cultures of hepatocytes induced by HGF/SF, EGF and TGF alpha in a chemically defined (HGM) medium , 1996, The Journal of cell biology.

[20]  J. Stange,et al.  A Carrier-Mediated Transport of Toxins in a Hybrid Membrane. Safety Barrier between a Patients Blood and a Bioartificial Liver , 1996, The International journal of artificial organs.

[21]  Pao C. Chau,et al.  Modeling of Axial‐Flow Hollow Fiber Cell Culture Bioreactors , 1996 .

[22]  Y. Sakai,et al.  Comparisons of Porcine Hepatocyte Spheroids and Single Hepatocytes in the Non-Woven Fabric Bioartificial Liver Module , 1996, The International journal of artificial organs.

[23]  Importance of the Kinetic Characterization of Liver Cell Metabolic Reactions to the Design of Hybrid Liver Support Devices , 1996, The International journal of artificial organs.

[24]  R. Hughes,et al.  Use of Bioartificial and Artificial Liver Support Devices , 1996, Seminars in liver disease.

[25]  V. Dixit,et al.  Artificial liver support: state of the art. , 1996, Scandinavian journal of gastroenterology. Supplement.

[26]  E. Drioli,et al.  The Effect of Oxygen Transport Resistances on the Viability and Functions of Isolated Rat Hepatocytes , 1996, The International journal of artificial organs.

[27]  R Williams,et al.  Pilot‐controlled trial of the extracorporeal liver assist device in acute liver failure , 1996, Hepatology.

[28]  A. Demetriou,et al.  Clinical experience with a bioartificial liver in the treatment of severe liver failure. A phase I clinical trial. , 1997, Annals of surgery.

[29]  Experimental evaluation of a hybrid liver support system. , 1997, Transplantation proceedings.

[30]  M. Meissler,et al.  Immunoisolation of Hybrid Liver Support Systems by Semipermeable Membranes , 1997, The International journal of artificial organs.

[31]  A. Demetriou,et al.  Treatment of Severe Liver Failure with a Bioartificial Liver a , 1997, Annals of the New York Academy of Sciences.

[32]  Roger Williams,et al.  Pilot-controlled trial of the extracorporeal liver assist device in acute liver failure , 1997 .

[33]  N Ohshima,et al.  Packed-bed type reactor to attain high density culture of hepatocytes for use as a bioartificial liver. , 2008, Artificial organs.

[34]  L. Flendrig,et al.  Possible Immunological Problems of Bioartificial Liver Support , 1997, The International journal of artificial organs.

[35]  Yasuhiro Takeuchi,et al.  Infection of human cells by an endogenous retrovirus of pigs , 1997, Nature Medicine.

[36]  A. Sheil,et al.  Simple and reliable methods to assess hepatocyte viability in bioartificial liver support system matrices. , 1997, Artificial organs.

[37]  M. Kodama,et al.  Hepatocytes entrapped in collagen gel following 14 days of storage at 4 degrees C: preservation of hybrid artificial liver. , 2008, Artificial organs.

[38]  N. Sussman,et al.  Extracorporeal liver support: cell-based therapy for the failing liver. , 1997, American journal of kidney diseases : the official journal of the National Kidney Foundation.

[39]  L. Flendrig,et al.  Commercially Available Media for Flushing Extracorporeal Bioartificial Liver Systems Prior to Connection to the Patient's Circulation: An in vitro Comparative Study in Two and Three Dimensional Porcine Hepatocyte Cultures , 1998, The International journal of artificial organs.

[40]  M. Makuuchi,et al.  Efficacy of a bioreactor filled with porcine hepatocytes immobilized on nonwoven fabric for ex vivo direct hemoperfusion treatment of liver failure in pigs. , 1998, Artificial organs.

[41]  K. Ookawa,et al.  Hepatocyte culture utilizing porous polyvinyl formal resin maintains long-term stable albumin secretion activity. , 1998, Journal of biomaterials science. Polymer edition.

[42]  H. Moriwaki,et al.  Removal of endotoxin and cytokines by plasma exchange in patients with acute hepatic failure. , 1998, Critical care medicine.

[43]  M. Toner,et al.  Microfabrication of Hepatocyte/Fibroblast Co‐cultures: Role of Homotypic Cell Interactions , 1998, Biotechnology progress.

[44]  Kohji Nakazawa,et al.  Hepatocyte Spheroids in Polyurethane Foams: Functional Analysis and Application for a Hybrid Artificial Liver , 1998 .

[45]  N Ohshima,et al.  Improvement of metabolic performance of hepatocytes cultured in vitro in a packed-bed reactor for use as a bioartificial liver. , 1998, ASAIO journal.

[46]  C. Mullon,et al.  Evidence of absence of porcine endogenous retrovirus (PERV) infection in patients treated with a bioartificial liver support system. , 1999, Artificial organs.

[47]  M. Löhr,et al.  Molecular adsorbent recycling system (MARS): clinical results of a new membrane-based blood purification system for bioartificial liver support. , 1999, Artificial organs.

[48]  L. Flendrig,et al.  Significantly Improved Survival Time in Pigs with Complete Liver Ischemia Treated with a Novel Bioartificial Liver , 1999, The International journal of artificial organs.

[49]  C. Selden,et al.  Three‐dimensional in Vitro Cell Culture Leads to a Marked Upregulation of Cell Function in Human Hepatocyte Cell Lines‐an Important Tool for the Development of a Bioartificial Liver Machine , 1999, Annals of the New York Academy of Sciences.

[50]  R. Hughes,et al.  Temporary Extracorporeal Liver Support for Severe Acute Alcoholic Hepatitis Using the Biologic-Dt , 1998, The International journal of artificial organs.

[51]  R. Busuttil,et al.  Characterization of human xenoreactive antibodies in liver failure patients exposed to pig hepatocytes after bioartificial liver treatment: an ex vivo model of pig to human xenotransplantation. , 1999, Transplantation.

[52]  P. Neuhaus,et al.  Enzyme release in hybrid liver support systems: marker for quality prior to clinical application. , 1999, Transplantation proceedings.

[53]  D H Persing,et al.  Transfer of porcine endogenous retrovirus across hollow fiber membranes: significance to a bioartificial liver. , 1999, Transplantation.

[54]  Y. Ikada,et al.  In vitro evaluation of metabolic functions of a bioartificial liver. , 1999, ASAIO journal.

[55]  A. Demetriou,et al.  Clinical Use of a Bioartificial Liver in the Treatment of Acetaminophen-Induced Fulminant Hepatic Failure , 1999, The American surgeon.

[56]  T. Tani,et al.  Bioartificial liver support system using porcine hepatocytes entrapped in a three-dimensional hollow fiber module with collagen gel: An evaluation in the swine acute liver failure model. , 1999, Artificial organs.

[57]  L. Flendrig,et al.  Evaluation of a novel bioartificial liver in rats with complete liver ischemia: treatment efficacy and species-specific alpha-GST detection to monitor hepatocyte viability. , 1999, Journal of hepatology.

[58]  Y. Sakai,et al.  A New Bioartificial Liver Using Porcine Hepatocyte Spheroids in High-Cell-Density Suspension Perfusion Culture: In Vitro Performance in Synthesized Culture Medium and in 100% Human Plasma , 1999, Cell transplantation.

[59]  M. T. Donato,et al.  Characterization of drug metabolizing activities in pig hepatocytes for use in bioartificial liver devices: comparison with other hepatic cellular models. , 1999, Journal of hepatology.

[60]  K Sugimachi,et al.  Evaluation of a hybrid artificial liver using a polyurethane foam packed-Bed culture system in dogs. , 1999, The Journal of surgical research.

[61]  G. Mazariegos,et al.  Novel Bioartificial Liver Support System: Preclinical Evaluation , 1999, Annals of the New York Academy of Sciences.

[62]  M. Toner,et al.  Numerical model of fluid flow and oxygen transport in a radial-flow microchannel containing hepatocytes. , 1999, Journal of biomechanical engineering.

[63]  J. Furui,et al.  Comparative study of bioartificial liver support and plasma exchange for treatment of pigs with fulminant hepatic failure. , 2000, Artificial organs.

[64]  Morphologic studies of hepatocytes entrapped in hollow fibers of a bioartificial liver. , 2000, ASAIO journal.

[65]  M. Degré,et al.  Pig endogenous retrovirus – a threat to clinical xenotransplantation? , 2000, APMIS : acta pathologica, microbiologica, et immunologica Scandinavica.

[66]  A. Veitch,et al.  Oxygen transfer in a diffusion-limited hollow fiber bioartificial liver. , 2000, Artificial organs.

[67]  C. Legallais,et al.  Design of a fluidized bed bioartificial liver. , 2000, Artificial organs.

[68]  P. Hayes,et al.  Animal models of fulminant hepatic failure: A critical evaluation , 2000, Liver transplantation : official publication of the American Association for the Study of Liver Diseases and the International Liver Transplantation Society.

[69]  A. Donini,et al.  Is PERV transfer across hollow fiber membranes relevant to bioartificial liver model? , 2000, Transplantation.

[70]  M. Toner,et al.  In Vitro Characterization of Porcine Hepatocyte Function , 2000, Cell transplantation.

[71]  G. Mazariegos,et al.  First Clinical Use of a Novel Bioartificial Liver Support System (BLSS) † , 2002, American journal of transplantation : official journal of the American Society of Transplantation and the American Society of Transplant Surgeons.